Questionnary
Otherquestionnary on predictif factors about physiological hypermetabolism of anal canal
NCT Number: NCT03506529
Questionnaire to be completed by patients coming for PET to identify the predictive factors of physiological hypermetabolism of the anal canal
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
CHU, Caen, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
questionnary on predictif factors about physiological hypermetabolism of anal canal
Time frame: Only at the day of inclusion, during an appointment for a TEP exam
Confrontation in participants of hypermetabolism of the anal canal in PET with:
number of stool/day and consistency of stool, medical history (by Answers to the specific questionnaire designed for the study)
Time frame: Only at the day of inclusion, during an appointment for a TEP exam
Visual analysis of hypermetabolism of the anal canal on a 3-point scale:
0: no hypermetabolism
Time frame: Only at the day of inclusion, during an appointment for a TEP exam
measurement of the largest rectal diameter in mm.
Time frame: Only at the day of inclusion, during an appointment for a TEP exam
Visual assessment of the rectal capacity on a 3-point scale (0, 1, 2) and content characteristics (air, feces, air and feces).
Centre Francois Baclesse
Other
Acronym: HYPHYCA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04287868
Anal Cancer, Anus Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT02697084
Anal Cancer, Anus Diseases
Nice, France
View Trial DetailsNCT05510908
AIDS Related Lymphoma, AIDS-Related Kaposi Sarcoma
La Jolla, California, United States
View Trial DetailsNCT04157985
Adenocarcinoma, Advanced Solid Tumors
Pittsburgh, Pennsylvania, United States
View Trial Details